BGA
AMGN icon

Belmont Global Advisors’s Amgen AMGN Stock Holding History

Belmont Global Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,200
Closed -$497K – 124
2014
Q2 		$497K Hold
4,200
– – 0.36% 76
2014
Q1 		$518K Buy
+4,200
New +$509K 0.44% 65

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Belmont Global Advisors's AMGN Position: Q3 2014 in Review

Belmont Global Advisors sold out of Amgen (AMGN) in Q3 2014, closing a stake of 4,200 shares — an estimated $497K sold.

Belmont Global Advisors first reported a position in AMGN in Q1 2014 and held it in 2 quarters. The position peaked at $518K in Q1 2014. 1,222 funds tracked by Wall St. Rank hold AMGN as of Q3 2014.

  • Belmont Global Advisors reported no remaining Amgen position as of Q3 2014 after selling out during the quarter.
  • Belmont Global Advisors sold 4,200 Amgen shares in Q3 2014, an estimated $497K.
  • Belmont Global Advisors first reported a position in Amgen in Q1 2014 and held it in 2 quarters.
  • Belmont Global Advisors's Amgen position peaked at $518K in Q1 2014.
  • 1,222 funds tracked by Wall St. Rank held Amgen as of Q3 2014.

Based on Belmont Global Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.